Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Cencora Community
NYSE:COR Community
1
Narratives
written by author
0
Comments
on narratives written by author
34
Fair Values set
on narratives written by author
Community Investing Ideas
Cencora
Popular
Undervalued
Overvalued
COR
Cencora
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Digital Infrastructure And Specialty Services Will Redefine Healthcare Delivery
Key Takeaways Digital investments and capital allocation enhance efficiency, margin expansion, and strengthen Cencora's competitive edge amid regulatory and industry shifts. Specialty drug demand, aging populations, and targeted acquisitions support sustained revenue growth and long-term earnings resilience.
View narrative
US$333.29
FV
12.1% undervalued
intrinsic discount
6.77%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
COR
COR
Cencora
Your Fair Value
US$
Current Price
US$292.82
6.3% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-4b
432b
2015
2018
2021
2024
2025
2027
2030
Revenue US$432.4b
Earnings US$2.6b
Advanced
Set Fair Value